Effect of intravenous FCM therapy on myocardial work indices in patients with HFrEF and ID.

Back

HFA Premium Access

Effect of intravenous FCM therapy on myocardial work indices in patients with HFrEF and ID.

Session: ePosters in chronic heart failure - treatment 5

Topic: Pharmacotherapy

Speaker: Professor A. Safarova (Baku, AZ)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Professor Ayten Safarova

Baku Health Center, Baku (Azerbaijan)

1 follower

5 more presentations in this session

The impact of modifiable risk factors on readmissions during the vulnerable period in patients with heart failure

Speaker: Assistant Professor A. Lacraru (Bucharest, RO)

AZD3427, a relaxin mimetic in pulmonary hypertension group 2 associated with left heart disease: design and rationale of the phase 2b Re-PHIRE Study

Speaker: Professor M. Ufnal (Gothenburg, SE)

Prospective evaluation of sacubitril/valsartan utilization patterns and clinical outcomes in Korean patients with heart failure with reduced ejection fraction: real-world post-marketing surveillance

Speaker: Professor J. Choi (Seoul, KR)

ARNi treatment in adults with Tetralogy of Fallot: a single-centre experience

Speaker: Doctor A. Ferreira (Lisbon, PT)

Effect of guideline-recommended medical therapy according to blood urea nitrogen

Speaker: Doctor P. Tolomeo (Glasgow, GB)

Access the full session

ePosters in chronic heart failure - treatment 5

Speakers: Professor A. Safarova, Assistant Professor A. Lacraru, Professor M. Ufnal, Professor J. Choi, Doctor A. Ferreira...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources